FentaNYL Citrate 2 — Class III drug recall D-0172-2023
Terminated recall by OurPharma LLC, reported 2023-02-01, distributed in IL, MO. Short Fill: Underfilled units.
| Recall number | D-0172-2023 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | OurPharma LLC, Fayetteville, AR, United States |
| Recall initiated | 2023-01-13 |
| Classified | 2023-01-23 |
| Reported by FDA | 2023-02-01 |
| Terminated | 2024-09-20 |
| Distributed | IL, MO |
| Quantity | 768 cassettes |
| NDC | 73013-1001-01 |
| Lot numbers | 100122080003, 100122090001, 100122100002 |
| Expiration dates | 2023-02-26, 2023-03-07, 2023-04-05 |
Product
FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1001-01.
Reason for recall
Short Fill: Underfilled units.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0172-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.